|
Neonatal Intensive Care Drug Manual
|
| bet | 339/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Drug Type
|
Electrolyte
|
Trade Name
|
DBL Magnesium Sulfate Concentrated Injection (Hospira),
MagMin Tablets (Blackmores),
Mag-Sup Tablets (Petrus)
|
Presentation
|
IV/IM:
IV: 4.93 g magnesium sulfate /10 mL ampoule (49.3% solution) OR,
2.465 g magnesium sulfate /5 mL.
Both preparations provide 10 mmol magnesium/5mL,
PO:
MagMin 500 mg magnesium aspartate tablets.
Mag-Sup 500 mg magnesium aspartate tablets.
500 mg magnesium aspartate tablet contains 37.4 mg (1.5 mmol) of elemental Mg.
|
Dosage / Interval
|
Hypomagnesaemia
25–50 mg magnesium sulfate/kg IV infusion over 30–60 minutes. Repeat if necessary.
Chronic hypomagnesaemia
PO: 187 mg of elemental magnesium per m2/day in divided doses. (Endocrine team, personal email communication) (=2500 mg magnesium aspartate per m2/day)
Body Surface Area (BSA) calculation:
|
|
| |
